- About the College
- Departments & Offices
- Veterinary Hospitals
NIH grant to renovate lab space in Goss Laboratory; Osteoporosis drug reduces bone loss, tumor size in oral cancer; Selected publications...; Staff feature; Announcements; Wellness news...
In December, the College of Veterinary Medicine hosted a reception to honor Dr. Michael Lairmore, associate dean for Research and Graduate Studies, professor, Department of Veterinary Biosciences, and associate director for Shared Resources at the Ohio State University Comprehensive Cancer Center (OSUCCC), who was recently named to the Institute of Medicine, one of the highest honors awarded to scientists in the biomedical fields.
Since 2008, the WEB services team at the Prior Health Sciences Library and Center for Knowledge Management has partnered with The Ohio State University College of Veterinary Medicine.
According to a study published in the latest issue of the Journal of the American Veterinary Medical Assocation, healthy cats are just as likely as chronically ill cats to exhibit "sickness behaviors" such as refusing food, vomiting, and leaving waste in inappropriate places, when their routines are disrupted. The research was conducted by Judi Stella, doctoral candidate, as part of a long-term study on environmental enrichment. The papers other co-authors include Dr. Tony Buffington, professor, Department of Veterinary Clinical Sciences and Dr.
Dr. Michael Lairmore, professor and associate dean of research and graduate studies, has been appointed the associate director for Shared Resources at the Ohio State University Comprehensive Cancer Center (OSUCCC).
A drug currently approved for osteoporosis treatment has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as an important supplemental therapy in patients with head and neck cancers that erode bone. Dr. Tom Rosol, professor in the department of veterinary biosciences, was the principle investigator in the Ohio State study. The drug treatment also was associated with smaller tumors – an unexpected result. The drug, zoledronic acid, is known by the brand name Zometa.
The College of Veterinary Medicine partners with the College of Public Health to offer the country's only Veterinary Public Health specialization towards the Master of Public Health degree. With the realization that nearly 70 percent of emerging diseases are likely to be zoonotic, the MPH-VPH degree was developed to prepare public health professionals to better protect the communities they serve. The program is open to veterinarians, as well as other professionals, including students with science backgrounds interested in public health.
Dr. John Hubbell, professor of veterinary anesthesiology and equine section head, was recently interviewed at the American Association of Equine Practitioners (AAEP) Annual Convention and Trade Show. To watch his interview on sedatives and anesthetics in horses, click here.
About the College of Veterinary Medicine at Ohio State